Congenital adrenal hyperplasia: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
_NOTOC__ | |||
'''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | '''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | ||
| Line 13: | Line 14: | ||
OMIM_mult = {{OMIM2|201710}} {{OMIM2|202110}} {{OMIM2|201810}} {{OMIM2|202010}}| | OMIM_mult = {{OMIM2|201710}} {{OMIM2|202110}} {{OMIM2|201810}} {{OMIM2|202010}}| | ||
MedlinePlus = 000411 | | MedlinePlus = 000411 | | ||
MeshID = D000312 | | MeshID = D000312 | | ||
}} | }} | ||
| Line 24: | Line 23: | ||
==[[Congenital adrenal hyperplasia overview|Overview]]== | ==[[Congenital adrenal hyperplasia overview|Overview]]== | ||
==Classification== | == [[Congenital adrenal hyperplasia classification|Classification]]== | ||
[[Congenital adrenal hyperplasia classification#Types of CAH|Types of CAH]] | [[Congenital adrenal hyperplasia classification#Genetics|Genetics]] | [[Congenital adrenal hyperplasia classification#Biochemistry|Biochemistry]] | [[Congenital adrenal hyperplasia classification#Types of CAH|Types of CAH]] | [[Congenital adrenal hyperplasia classification#Genetics|Genetics]] | [[Congenital adrenal hyperplasia classification#Biochemistry|Biochemistry]] | ||
Revision as of 04:44, 22 August 2012
_NOTOC__ For patient information click here
| Congenital adrenal hyperplasia | |
 | |
|---|---|
| Cortisol | |
| ICD-10 | E25.0 |
| ICD-9 | 255.2 |
| OMIM | 201910 201710 202110 201810 202010 |
| DiseasesDB | 1854 Template:DiseasesDB2 Template:DiseasesDB2 Template:DiseasesDB2 Template:DiseasesDB2 |
| MedlinePlus | 000411 |
| MeSH | D000312 |
|
Congenital adrenal hyperplasia main page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Classification
Types of CAH | Genetics | Biochemistry
Historical Perspective
Pathophysiology
Epidemiology & demographics
Risk factors
Screening
Causes
Differentiating congenital adrenal hyperplasia from other diseases
Natural History, Complications & Prognosis
Diagnosis
History & Symptoms | Physical examination | Lab Tests | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical therapy: 21-Hydroxylase | 11-Hydroxylase
Surgical therapy: Surgery
Prevention: Primary prevention | Secondary prevention
CAH due to 21-hydroxylase deficiency
- Clinical onset:
- Diagnosis: Newborn screening | Prenatal diagnosis
- Long-term management: Hormone replacement | Stress coverage, crisis prevention, parental education | Reconstructive surgery | Optimizing growth | Optimizing androgen suppression and fertility | Psychosexual development and issues
Related chapters
Resources
- CARES Foundation: Congenital Adrenal Research, Education, and Support
- CongenitalAdrenalHyperplasia.org
- Congenital Adrenal Hyperplasia: A Handbook for Parents
- The ABC's of Congenital Adrenal Hyperplasia
- Organization for Rare Disorders (NORD): Adrenal Hyperplasia, Congenital
- Guide to Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency for parents or patients from Johns Hopkins
- A more advanced discussion of 21-hydroxylase deficiency by an eminent researcher of the disease.
- MAGIC Foundation: Family Support, Annual Convention with Families and Medical Experts
de:Adrenogenitales Syndrom it:Iperplasia surrenale congenita nl:Adrenogenitaal syndroom